ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 0865

Z’s and Knees: Associations of Participant-reported and Objective Sleep Measures with Pain Among US Veterans with Osteoarthritis of the Knee

David Azizi1, Sarah Wetzel1, Marianna Olave1, Rachel Gillcrist2, Hannah Brubeck3, Daniel White4, Carla Scanzello5, Tuhina Neogi6, Alexis Ogdie7, Bryant England8, Mercedes Quinones9, Katherine Wysham10 and Joshua Baker11, 1Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, 2Corporal Michael J. Crescenz VA Medical Center, Philadelphia, 3VA Puget Sound Health Care System, Seattle, WA, 4University of Delaware, Newark, DE, 5University of Pennsylvania, Philadelphia, PA, 6Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 7Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 8University of Nebraska Medical Center, Omaha, NE, 9Washington DC VA Medical Center, Bethesda, MD, 10VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 11Department of Medicine, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA

Meeting: ACR Convergence 2024

Keywords: mental health, Osteoarthritis, pain, physical activity, sleep

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Abstracts: Osteoarthritis – Novel Insights from Observational Studies

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Inadequate sleep is associated with a range of poor health outcomes, including chronic health conditions, mood disorders, and all-cause mortality. There is some evidence that sleep-related problems contribute to chronic pain disorders, but the relationship between sleep and pain remains poorly defined, particularly among patients with knee osteoarthritis (KOA). To our knowledge, prior studies have not evaluated the association between patient-reported and objective sleep measures with pain among people with KOA.

Methods: We evaluated baseline data from 206 Veterans with KOA in a clinical trial designed to examine the effect of physical activity incentives and corticosteroid injections on patient-reported pain and function. During a pre-randomization enrollment period, sleep was measured using the validated patient-reported Pittsburgh Sleep Quality Index (PSQI) and objective sleep duration by wrist activity monitors (Fitbit). PSQI scores above 5 and average total sleep time (TST) less than 7 hours were considered ‘inadequate’ based on prior definitions. Self-reported knee pain and objectively measured regional pain sensitivity were assessed with the Knee Injury and Osteoarthritis Outcome Score (KOOS) and pain pressure threshold testing (PPT) on the participant-identified worse knee, respectively. KOA severity was measured by the Kellgren-Lawrence (KL) grading system. We used linear regression to model the unadjusted and adjusted relationship between sleep measures and pain outcomes. We also explored other predictors of patient-reported pain and pain sensitization in models adjusted for age, gender, race, anxiety, and average daily step count.

Results: Inadequate sleep was common; 164 (80%) and 160 (78%) met criteria by subjective and objective assessments, respectively. Agreement between subjective and objective sleep was poor (κ 0.01). Individuals with inadequate sleep by PSQI were younger and more likely to have anxiety and depression and had significantly worse PPT at the knee. Those identifying as Black or another race were more likely than White individuals to have inadequate objective sleep by TST, as were those with fibromyalgia, higher average step counts, and higher KOOS (Table 1).
In adjusted models, participant-reported sleep was significantly associated with pain sensitivity (PPT) and pain severity (KOOS pain), while objective sleep was not associated with either measure (Figure 1). The diagnosis of anxiety significantly increased KOOS pain but not PPT. Both were ameliorated by age (Figure 2). 

Conclusion: Most participants had inadequate sleep by both participant-reported and objective measures, illustrating extent of poor sleep among Veterans with KOA. The report of poor sleep, but not objective assessments of inadequate sleep duration, was associated with worse pain and worse regional pain sensitivity. These observations suggest that perception of poor sleep is more relevant to how patients with KOA experience pain. Anxiety and depression were associated with poorer sleep and were the largest contributors to worse self-reported pain. Further research should elucidate additional mediators and potential interventions for patients with KOA who report poorer sleep. 

Supporting image 1

Figure 1: Pain measures (KOOS pain on left; pain sensitivity at knee on right) in patients with inadequate sleep duration by Fitbit and inadequate sleep by self-report, adjusting for age, sex, race, average steps per day, and a diagnosis of anxiety.

Supporting image 2

Figure 2: Standardized differences in pain sensitivity at the knee and self-reported pain (KOOS pain) by clinical characteristic (standardized regression coefficients).

Supporting image 3

Table 1: Characteristics of patients with adequate and inadequate sleep as defined by self-report and Fitbit objective assessments.


Disclosures: D. Azizi: None; S. Wetzel: None; M. Olave: None; R. Gillcrist: None; H. Brubeck: None; D. White: None; C. Scanzello: None; T. Neogi: Amgen, 2, Eli Lilly, 2, GlaxoSmithKlein(GSK), 2, Novartis, 2, Sobi, 2; A. Ogdie: AbbVie, 2, 5, Amgen, 2, 5, Bristol Myers Squibb, 2, Celgene, 2, CorEvitas, LLC, 2, Eli Lilly and Company, 2, Gilead, 2, GSK, 2, Janssen, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Takeda, 2, UCB Pharma, 2; B. England: Boehringer-Ingelheim, 5; M. Quinones: CVS Caremark, 2, Pfizer, 5; K. Wysham: None; J. Baker: CorEvitas, LLC, 2, Cumberland Pharma, 2, Formation Bio, 2, Horizon, 5.

To cite this abstract in AMA style:

Azizi D, Wetzel S, Olave M, Gillcrist R, Brubeck H, White D, Scanzello C, Neogi T, Ogdie A, England B, Quinones M, Wysham K, Baker J. Z’s and Knees: Associations of Participant-reported and Objective Sleep Measures with Pain Among US Veterans with Osteoarthritis of the Knee [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/zs-and-knees-associations-of-participant-reported-and-objective-sleep-measures-with-pain-among-us-veterans-with-osteoarthritis-of-the-knee/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/zs-and-knees-associations-of-participant-reported-and-objective-sleep-measures-with-pain-among-us-veterans-with-osteoarthritis-of-the-knee/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology